AU Patent

AU2024240793A1 — Methods for treating nervous system disorders

Assigned to Regulus Therapeutics Inc · Expires 2025-09-11 · 1y expired

What this patent protects

Provided herein are methods for the treatment of a nervous system disorder, including epilepsy, using modified oligonucleotides that inhibit AMPAR.

USPTO Abstract

Provided herein are methods for the treatment of a nervous system disorder, including epilepsy, using modified oligonucleotides that inhibit AMPAR.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024240793A1
Jurisdiction
AU
Classification
—
Expires
2025-09-11
Drug substance claim
No
Drug product claim
No
Assignee
Regulus Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.